发明名称 |
3-phenoxymethylpyrrolidine compounds |
摘要 |
In one aspect, the invention relates to compounds of formula I:;
where R1-6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds. |
申请公布号 |
US9227933(B2) |
申请公布日期 |
2016.01.05 |
申请号 |
US201514594382 |
申请日期 |
2015.01.12 |
申请人 |
Theravance Biopharma R&D IP, LLC |
发明人 |
Stangeland Eric;Saito Daisuke Roland;Van Dyke Priscilla;Patterson Lori Jean |
分类号 |
C07D207/08;A61K45/06;A61K31/40 |
主分类号 |
C07D207/08 |
代理机构 |
|
代理人 |
Hagenah Jeffrey A. |
主权项 |
1. A compound of formula I:where:
R1 is isopropyl; R2 through R6 are independently selected from hydrogen, halo, —C1-6alkyl, —CF3, —O —C1-6alkyl, —CN, —C(O)—C1-6alkyl, —S—C1-6alkyl, —C3-8cycloalkyl, and —NO2; or R4 and R5 are taken together to form —CH═CH—CH═CH—; or R5 and R6 are taken together to form —CH═CH—CH═CH—; or a pharmaceutically acceptable salt thereof. |
地址 |
South San Francisco CA US |